MOH — authorised 10 October 2019
- Marketing authorisation holder: VERTEX PHARMS INC
- Status: likely_approved
🇮🇱 Trikafta (Copackaged) in Israel
MOH authorised Trikafta (Copackaged) on 10 October 2019
Marketing authorisation
Trikafta (Copackaged) in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in Israel
Frequently asked questions
Is Trikafta (Copackaged) approved in Israel?
Yes. MOH authorised it on 10 October 2019.
Who is the marketing authorisation holder for Trikafta (Copackaged) in Israel?
VERTEX PHARMS INC holds the Israeli marketing authorisation.